Mcrae Capital Management Inc Eli Lilly & CO Transaction History

Mcrae Capital Management Inc

$458 Million
Q2 2025

A detailed history of Mcrae Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mcrae Capital Management Inc holds 936 shares of LLY stock, worth $748,397. This represents 0.16% of its overall portfolio holdings.

Number of Shares

936

Previous 1,041 10.09%

Holding current value

$748,397

Previous $859,000 15.13%

% of portfolio

0.16%

Previous 0.19%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$713.71 - $898.95 $74,939 - $94,389	-105 Reduced 10.09%	936 $729,000
Q1 2025 May 13, 2025	SELL	$725.72 - $929.72 $14,514 - $18,594	-20 Reduced 1.89%	1,041 $859,000
Q4 2024 Jan 29, 2025	SELL	$727.2 - $932.06 $7,272 - $9,320	-10 Reduced 0.93%	1,061 $819,000
Q3 2024 Oct 24, 2024	SELL	$772.14 - $960.02 $38,607 - $48,001	-50 Reduced 4.46%	1,071 $948,000
Q1 2024 Apr 18, 2024	SELL	$592.2 - $792.28 $65,142 - $87,150	-110 Reduced 8.94%	1,121 $872,000
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $71,725 - $98,884	-165 Reduced 11.82%	1,231 $661,000
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $17,537 - $23,449	-50 Reduced 3.46%	1,396 $654,000
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $59,019 - $69,315	-190 Reduced 11.61%	1,446 $496,000
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $40,193 - $46,833	-125 Reduced 7.1%	1,636 $0
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $250,229 - $285,162	-844 Reduced 32.4%	1,761 $569,000
Q2 2022 Jul 20, 2022	BUY	$278.73 - $327.27 $51,007 - $59,890	183 Added 7.56%	2,605 $845,000
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $22,485 - $27,904	-100 Reduced 3.97%	2,422 $669,000
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $13,046 - $17,263	100 Added 4.13%	2,522 $426,000
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $5,729 - $6,895	-42 Reduced 1.7%	2,422 $398,000
Q1 2020 Apr 16, 2020	BUY	$119.05 - $147.35 $40,715 - $50,393	342 Added 16.12%	2,464 $342,000
Q3 2019 Oct 21, 2019	SELL	$106.79 - $116.16 $56,812 - $61,797	-532 Reduced 20.05%	2,122 $237,000
Q3 2018 Oct 15, 2018	SELL	$85.86 - $107.31 $8,586 - $10,731	-100 Reduced 3.63%	2,654 $285,000
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $28,679 - $30,761	-350 Reduced 11.28%	2,754 $233,000
Q3 2017 Oct 23, 2017	BUY	$77.07 - $85.54 $239,225 - $265,516	3,104	3,104 $266,000

Others Institutions Holding LLY

# of Institutions

4,449

Shares Held

781M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Account

Mcrae Capital Management Inc Eli Lilly & CO Transaction History